Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3356 |
|
Actual shortage: | 218 (6%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 10 (0%) | |
Resolved: | 3128 (93%) | |
Discontinuation Reports |
359 |
|
To be discontinued: | 24 (7%) | |
Discontinued: | 335 (93%) | |
Reversed: | 0 (0%) | |
Late reports |
144 (4%) |
|
Overdue reports |
61 (25%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-05-19 | 2023-06-16 | 192812 |
APO-ROSUVASTATIN | 20MG | TABLET | Resolved | 2023-08-12 | 2023-08-23 | 201710 |
APO-ROSUVASTATIN | 40MG | TABLET | Resolved | 2023-08-23 | 2023-09-01 | 202827 |
APO-SALBUTAMOL HFA | 100MCG | METERED-DOSE AEROSOL | Resolved | 2023-07-13 | 2024-05-31 | 198539 |
APO-SALBUTAMOL HFA | 100MCG | METERED-DOSE AEROSOL | Resolved | 2019-10-23 | 2019-12-23 | 97054 |
APO-SALBUTAMOL HFA | 100MCG | METERED-DOSE AEROSOL | Resolved | 2020-03-18 | 2020-09-14 | 108970 |
APO-SALBUTAMOL HFA | 100MCG | METERED-DOSE AEROSOL | Resolved | 2025-01-10 | 2025-04-04 | 247455 |
APO-SALBUTAMOL HFA | 100MCG | METERED-DOSE AEROSOL | Resolved | 2022-03-09 | 2022-06-17 | 156387 |
APO-SALBUTAMOL HFA | 100MCG | METERED-DOSE AEROSOL | Resolved | 2021-12-24 | 2021-12-31 | 151892 |
APO-SALVENT 5MG/ML | 5MG | SOLUTION | Actual shortage | 2017-08-13 | 2017-10-05 | 19000 |
APO-SALVENT AEM 100MCG | 100MCG | METERED-DOSE AEROSOL | Actual shortage | 2017-08-13 | 2017-10-05 | 18988 |
APO-SALVENT STERULES | 1MG | SOLUTION | Actual shortage | 2017-08-13 | 2017-10-05 | 19057 |
APO-SALVENT STERULES | 2MG | SOLUTION | Actual shortage | 2017-08-13 | 2017-10-05 | 19063 |
APO-SALVENT STERULES | 0.5MG | SOLUTION | Actual shortage | 2017-08-14 | 2017-10-05 | 19114 |
APO-SALVENT TABLETS - 4MG | 4MG | TABLET | Resolved | 2017-03-12 | 2017-05-10 | 689 |
APO-SALVENT-IPRAVENT STERULES | 0.5MG 2.5MG | SOLUTION | Actual shortage | 2017-08-14 | 2017-10-05 | 19323 |
APO-SAXAGLIPTIN | 5MG | TABLET | Resolved | 2024-10-24 | 2025-01-03 | 241063 |
APO-SAXAGLIPTIN | 5MG | TABLET | Resolved | 2021-12-10 | 2022-01-31 | 150896 |
APO-SAXAGLIPTIN | 2.5MG | TABLET | Resolved | 2022-01-14 | 2022-07-19 | 152773 |
APO-SAXAGLIPTIN | 5MG | TABLET | Resolved | 2022-02-04 | 2022-07-11 | 154208 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 |